CCR6通过上皮间质转化促进结直肠癌肝转移的机制研究  

CCR6 promotes liver metastasis of colorectal cancer through epithelial-mesenchymal transition

作　　者：张海利[1] 李娟芳 李晓晴 史淋洁 李袁飞[1] Zhang Haili;Li Juanfang;Li Xiaoqing;Shi Linjie;Li Yuanfei(Department of Oncology,First Hospital of Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学第一医院肿瘤科,太原030001

出　　处：《国际肿瘤学杂志》2020年第1期29-34,共6页Journal of International Oncology

基　　金：山西省卫生和计划生育委员会科研课题(2018042)。

摘　　要：目的检测人趋化因子受体6(CCR6)、人趋化因子配体20(CCL20)、E-钙黏着蛋白和波形蛋白在结直肠癌及肝转移组织中的表达,探讨CCR6参与结直肠癌肝转移的可能机制。方法选取山西医科大学第一医院及山西省肿瘤医院2009至2017年资料齐全的62例原发性结直肠癌患者(结肠癌54例、直肠癌8例)手术切除存档蜡块,其中包含同期切除结直肠癌伴肝转移病灶的标本20例。采用免疫组织化学法检测结直肠癌及肝转移组织中CCR6、CCL20、E-钙黏着蛋白和波形蛋白的表达情况,分析CCR6、E-钙黏着蛋白和波形蛋白的表达与患者临床病理特征之间的关系,采用logistic多因素回归分析肝转移与患者临床病理特征及CCR6、E-钙黏着蛋白和波形蛋白表达的关系,采用Spearman相关分析CCR6与E-钙黏着蛋白和波形蛋白的相关性。结果CCR6在结直肠癌组织中的阳性表达率为66.1%(41/62);在伴有肝转移的结直肠癌组织中的阳性表达率为85.0%(17/20),在肝转移组织中的阳性表达率为70.0%(14/20)。CCL20在结直肠癌中的阳性表达率为83.9%(52/62);在伴有肝转移的结直肠癌组织中的阳性表达率为90.0%(18/20),在肝转移组织中的阳性表达率为90.0%(18/20)。E-钙黏着蛋白在结直肠癌中的阳性表达率为67.7%(42/62);在伴有肝转移的结直肠癌组织中的阳性表达率为50.0%(10/20),肝转移组织中的阳性表达率为65.0%(13/20)。波形蛋白在结直肠癌组织中阳性表达率为79.0%(49/62);在伴有肝转移的结直肠癌组织中的阳性表达率为85.0%(17/20),在肝转移组织中的阳性表达率为90.0%(18/20)。CCR6的表达与淋巴结转移(χ^2=11.142,P=0.001)、肝转移(χ^2=4.694,P=0.030)、TNM分期(χ^2=21.785,P<0.001)密切相关;E-钙黏着蛋白的表达与患者淋巴结转移(χ^2=4.694,P=0.030)、肝转移(χ^2=4.253,P=0.039)、TNM分期(χ^2=7.867,P=0.005)密切相关;波形蛋白的表达与患者淋巴结转移(χ^2=7.293,P=0.007)、TNM分期(χ^2Objective To detect the expressions of chemokine receptor 6(CCR6),CC chemokine ligand 20(CCL20)E-cadherin and vimentin in tissues of colorectal cancer and their paired liver metastases,and to investigate the possible mechanism of CCR6 in liver metastasis of colorectal cancer.Methods A total of 62 cases(54 cases of colon cancer and 8 cases of rectal cancer)of primary colorectal adenocarcinoma resection with wax lumps were selected from the First Hospital of Shanxi Medical University and Shanxi Oncology Hospital from 2009 to 2017 with complete data,including 20 samples of colorectal cancer resection with liver metastasis during the same period.The expressions of CCR6,CCL20,E-cadherin and vimentin in colorectal cancer and liver metastases tissues were detected by immunohistochemistry,and the relationships between the expressions of CCR6,E-cadherin and vimentin and the clinicopathological features of patients were analyzed.Logistic multivariate regression was used to analyze the relationship between liver metastasis and clinicopathological features,CCR6,E-cadherin and vimentin.Spearman correlation was used to analyze the correlations between CCR6 and E-cadherin and vimentin.Results The positive expression rate of CCR6 in colorectal cancer tissues was 66.1%(41/62),85.0%(17/20)in colorectal cancer with liver metastasis and 70.0%(14/20)in liver metastasis tissues.The positive expression rate of CCL20 in colorectal cancer tissues was 83.9%(52/62),90.0%(18/20)in colorectal cancer with liver metastasis and 90.0%(18/20)in liver metastasis tissues.The positive expression rate of E-cadherin in colorectal cancer tissues was 67.7%(42/62),50.0%(10/20)in colorectal cancer with liver metastasis and 65.0%(13/20)in liver metastasis tissues.The positive expression rate of vimentin in colorectal cancer tissues was 79.0%(49/62),85.0%(17/20)in colorectal cancer with liver metastasis and 90.0%(18/20)in liver metastasis tissues.The expression of CCR6 was closely related to lymph node metastasis(χ^2=11.142,P=0.001),liver metastasis(χ^2=4

关 键 词：结直肠肿瘤 受体 CCR6 钙黏着糖蛋白类 波形蛋白 肝转移 

分 类 号：R735[医药卫生—肿瘤]